A-27 (ATRIPLEX POLYCARPA POLLEN, ATRIPLEX LENTIFORMIS POLLEN, and ATRIPLEX CANESCENS POLLEN)

**Product type:** Human Otc Drug

**Active ingredient:** ATRIPLEX CANESCENS POLLEN; ATRIPLEX LENTIFORMIS POLLEN; ATRIPLEX POLYCARPA POLLEN

**Strength:** 30; 30; 30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

**Dosage form:** Solution

**Route:** Sublingual

**Labeler:** DNA Labs, Inc.

**Marketing category:** UNAPPROVED HOMEOPATHIC

**Pharmacologic class:** Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS], Pollen [CS], Pollen [CS]